Albireo Pharma, Inc.
ALBODelisted Mar 2, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001322505
Albireo Pharma, Inc. was delisted on Mar 2, 2023; its insiders filed their last Form 4 on Mar 3, 2023; 96 institutions reported holding it in 13F filings for Q4 2022, worth $401.7M in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Albireo Pharma, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 96 | 1 | 3 | −92 |
| Shares | 18.6M | 300 | 46.1K | −18.6M (−99.8%) |
| Value | $401.7M | $6.48K | $2.04M | −$399.7M (−99.5%) |
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (0)
Institutions that held Albireo Pharma, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
None.
Sold out (92)
Institutions that held Albireo Pharma, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
Not filed for Q1 2023 yet (1)
Institutions that held Albireo Pharma, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Sargent Bickham Lagudis LLC | 300 | $6.48K |